🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🇺🇬 Rita from Kampala, Uganda, lives with #NMOSD. Symptoms began in May 2022 with vision loss and paralysis. After struggling to afford her treatment, she now receives care at Mulago National Referral Hospital. Inspired by TSF, she’s raising NMO awareness in Uganda. sumairafoundation.org/ritas-nmosd-st…

"The [#Family Reported Outcome Measure] FROM-16 could be used to measure the [#MultipleSclerosis] family #impact in routine practice to support family members appropriately and to include this impact in health economic appraisal and therapeutic clinical trials."

📢 June issue is now available ▶️journals.sagepub.com/toc/MSJ/current ...and the cover goes to kiːelements Tjalf Ziemssen TU Dresden with their study on speech analysis in #MultipleSclerosis▶️journals.sagepub.com/doi/abs/10.117…

📰 Our latest newsletter is here! We’ve packed this edition with all the essentials for your #ECTRIMS2025 planning. 📬 Catch up on important dates, recent activities, and educational content from the last three months. Read the newsletter ➡️ bit.ly/4eoElwb

Plasma 4S-hydroxycholesterol provides a minimally invasive biomarker of brain cholesterol metabolism and follows the effects of treatment with the remyelinating antibody rHIgM22 in #MultipleSclerosis. Study from UC Berkeley▶️ journals.sagepub.com/doi/full/10.11…

New article in the MSJ: A newly introduced JC virus assay classified 61.4% of MS patients as seropositive compared to just 23.6% with the reference test. The high rate of discrepancy challenges clinical decision-making. 🔗 Read the article here: bit.ly/4jZHGD5

Did you publish your first article as first author in 2024 on our journals? Apply to the 2025 F2 Award of MSJ and ECTRIMS with a cash prize and one year access to the #MSJ (stay tuned at the #ECTRIMS2025 Closing Ceremony) ▶️ journals.sagepub.com/msj/researcher… Deadline: Jul 19

Proud to be one of the co-authors of this series on gender affirming care and interventions in MS. Without trying to understand all types of people living with MS, we cannot claim to provide equitable care to all.

Dynamic contrast-enhanced MRI was used to evaluate blood–brain barrier permeability in #MultipleSclerosis, in relation to severity and timing of optic neuritis. Study from Lina Moschoula Passali Københavns Uni Rigshospitalet ▶️ journals.sagepub.com/doi/full/10.11…

Depression and fatigue should be addressed in the context of lifestyle recommendations in #MultipleSclerosis, to maximise the effect of cognitively enriching leisure activities. Study from University College Dublin ▶️ journals.sagepub.com/doi/full/10.11…

Rituximab showed superior effectiveness on MRI and clinical activity, compared to cladribine, over 4.5 years. Observational data from the Norwegian #MultipleSclerosis Registry and Biobank Universitetet i Bergen Universitetet i Oslo ▶️ journals.sagepub.com/doi/full/10.11…

By testing the SDMT monthly across 3 years, the plateau of practice effects was reached after 18 repetitions, suggesting that alternate versions and reliable-change methodologies should be considered. Study from Göteborgs universitet / University of Gothenburg Sahlgrenska Universitetssjukhuset ▶️ journals.sagepub.com/doi/full/10.11…

Excited to share this important work on delays to diagnosis of MS in Zambia that underscores the need for improved awareness, especially amongst HCWs MSJ Deanna Saylor journals.sagepub.com/doi/full/10.11…

Gynecological health within comprehensive treatment monitoring for #MultipleSclerosis. Topical review from Riley Bove UC San Francisco ▶️journals.sagepub.com/doi/full/10.11…

Thoroughly enjoyed the opportunity to write this controversy in MS article! #MS #multiplesclerosis

Black African people born and evaluated in Zambia experienced prolonged #MultipleSclerosis diagnostic delays when compared to non-black Zambians born and/or evaluated outside Zambia. Study from Deanna Saylor The University Of Zambia University of North Carolina at Chapel Hill ▶️journals.sagepub.com/doi/full/10.11…

Did you publish your first article as first author in 2024 on our journals? Apply to the 2025 F2 Award of MSJ and ECTRIMS with a cash prize and one year access to the #MSJ (stay tuned at the #ECTRIMS2025 Closing Ceremony) ▶️ journals.sagepub.com/msj/researcher… Deadline: Jul 19

κ-FLC index >100 at #MultipleSclerosis diagnosis predicts risk of relapse and disability accumulation after 10 years. Study from Medizinische Universitaet Innsbruck ▶️ journals.sagepub.com/doi/full/10.11…